News

Diagnostic health care is often restricted in areas with limited resources, because the procedures required to detect many of the molecular markers that can diagnose diseases are too complex or expensive to be used outside of a central laboratory.

Company has announced that it has applied the CE mark to expand the use of VeriSeq NIPT analysis software in clinical laboratories.

Patients could be spared the unpleasant ordeal of having blood taken in future thanks to the work of a University of the West of England (UWE Bristol) academic who has devised a new breath testing device.

Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.

Ordinary sugar could become a contrast agent of the future for use in magnetic resonance tomography examinations of tumours. Malignant tumours show higher sugar consumption than surrounding tissue.

Company has announced a diagnostic research collaboration with TESARO and Merck to help identify potential responders to an investigational combination drug therapy.

Company has announced that it has received medical device licenses from Health Canada's Therapeutic Products Directorate for ARIES System and ARIES HSV 1&2 Assay.

Researchers at Forties Clinic have announced that the sonographically guided Botulinum Toxin Type A (Dysport) injections into the Tensor Fasciae Latae for the treatment of Lateral Patellofemoral Overload Syndrome (LPOS).

A simple blood test that can accurately diagnose active tuberculosis could make it easier and cheaper to control a disease that kills 1.5 million people every year.

UCSF symposium explores vulnerability and malleability of microbes in human gut.